Three reasons why MedPAC’s latest Part D proposal would be bad for patients
By Tom Wilbur | July 14, 2020
The recently released Medicare Payment Advisory Commission’s (MedPAC) report to Congress recommends restructuring the Medicare Part D benefit and allowing plans greater flexibility to implement...
Read More
PhRMA’s Lori Reilly joined CSG to discuss the industry’s response to COVID-19 and what it means for states
By Sarah Sutton | July 13, 2020
Recently, Lori Reilly, Chief Operating Officer at PhRMA, participated in a podcast with the Council of State Governments (CSG) to discuss the important work the biopharmaceutical industry is doing...
Read More
R&D Focus: 5 things to know about the biopharmaceutical research ecosystem
By Jocelyn Ulrich | July 13, 2020
America’s biopharmaceutical companies are at the heart of a robust research and development (R&D) ecosystem that develops more innovative medicines than any other country in the world. In recent...
Read More
New initiative to bridge the gap on antimicrobial innovation
By Stephen J. Ubl | July 9, 2020
Today, more than 20 leading biopharmaceutical companies are launching the AMR Action Fund, a ground-breaking partnership to invest nearly $1 billion to ensure a robust and diverse pipeline of new...
Read More
The latest: What they are saying: Importance of intellectual property protections to combat COVID-19
By Tom Wilbur | July 2, 2020
America’s biopharmaceutical companies are committed to COVID-19 treatment and vaccine research and development (R&D). Reliable IP protections have helped drive innovation and enhance patient...
Read More
Guest Post: Pride started with protest: Combatting the dual pandemics of COVID-19 and racism this Pride Month
By Guest Contributor | June 30, 2020
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
How biopharmaceutical researchers are ensuring COVID-19 vaccines will be safe and effective
By Richard Moscicki, M.D. | June 29, 2020
As the world continues to feel the impact of COVID-19, the biopharmaceutical industry is working around the clock to identify and develop safe and effective vaccines to prevent infection, while...
Read More
Guest Post: Takeda seeks ‘new normal’ for cancer research during the COVID-19 pandemic
By Guest Contributor | June 24, 2020
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
In combating COVID-19, science is how we get back to normal
By Lori Reilly | June 24, 2020
America’s biopharmaceutical companies are working around the clock to combat a common enemy: COVID-19. As the fight to research and develop innovative treatments and vaccines advances, I’m pleased...
Read More
Guest post: A post-pandemic crisis: The mental toll on America
By Guest Contributor | June 16, 2020
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Medicare Monday (100)
340B Spotlight (43)
Cost & Consequence (0)
